
WAY Stock Forecast & Price Target
WAY Analyst Ratings
Bulls say
Waystar Holding Corp demonstrates a robust financial outlook, highlighted by a compound annual growth rate (CAGR) of 16% in revenue since 2022 and an expected uptick in 2024 following disruptions from the Change Healthcare cyberattack. The company has capitalized on the ambulatory sector's rapid revenue cycle, reflected in a market share increase to 8%, compared to 4% in hospitals and health systems, which positions it favorably in a growing market. Additionally, high-value clients, which constitute approximately 4.15% of the total clientele, experienced a quarter-over-quarter growth rate of 3.4% in 1Q25, underscoring the increasing demand for Waystar's cloud technology solutions.
Bears say
Waystar Holding Corp is facing a negative outlook primarily due to a projected decrease in revenue, with expectations of a sequential decline in 3Q and stagnation in 4Q, coinciding with a drop in capital expenditures as a percentage of revenue from previous years. Additionally, EBITDA has deteriorated significantly, standing at 2.2x at the end of 2Q, down from 6.4x at the end of 2023, indicating a significant decline in the company's operational efficiency and profitability. The potential impact of cybersecurity breaches, as experienced with Change Healthcare, poses a further risk to client relationships and the company's growth prospects, complicating its long-term objective of low-double digit annual revenue growth.
This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares